RA Capital — 2020 Investments
5 investments dated 2020 · listed companies and verified rows first · show all
Kinaset Therapeutics is a biopharmaceutical company developing respiratory drug therapies.
BiotechHealthtechMedfield, US
Tom King(Director of the Issuer)Roger Heerman(Chief Business/Operating Officer / Co-Founder)Frazer Morgan(Chief Development Officer / Co-Founder)Bram Vanparys(Director of the Issuer)Robert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)
Structure-based small-molecule drug design targeting protein aggregation diseases.
BiotechThousand Oaks, US
Gary Wilcox(Director)James Treanor(Also a former CEO)John Frank(Director)Madhavan Balachandran(Executive Officer, Director)
Board seatReza Halse· per SEC Form D · $6M raise · filed Dec 2020
Menlo Park, US
Michael Rabson(Executive Officer, Promoter)Kevin Judice(Executive Officer, Promoter)
Board seatJake Simson· per SEC Form D · $81.5M raise · filed Jan 2021
Werewolf Therapeutics is a biotechnology company developing immunotherapy treatments for cancer.
BiotechHealthtechMedical DevicesWatertown, US
Daniel J. Hicklin(Founder, President, Chief Executive Officer, and Board member)Luke Evnin(Co-founder, Board member (Chairman))Daniel Hicklin(Executive Officer, Director)Alon Lazarus(Director)David Cordo(Executive Officer)
BoardChristoph Westphal(Director)
Board seatDerek DiRocco· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.